Medicinal products (Community procedures for the authorisation and supervision of medicinal products)

This procedure concerns the rules for authorising and overseeing medicinal products within the EU. It aims to ensure that medicines available to consumers are safe, effective, and of high quality, protecting public health.

It affects pharmaceutical companies by setting standards for product development and marketing. Consumers benefit from clear information and guaranteed product safety.